Policy Notices

• Upcoming Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021
  (NOT-OD-20-127)
  National Institutes of Health
  

General Notices

• Notice of Technical Assistance Webinar: NIDCR Research Training Opportunities
  (NOT-DE-20-028)
  National Institute of Dental and Craniofacial Research
  

• Request for Information: Invitation for Input on Research Gaps and Opportunities related to the 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and their Caregivers
  (NOT-AG-20-035)
  National Institute on Aging
  

Notice of Changes to Funding Opportunities

• Notice to Extend the Expiration Date for PAR-18-434 "Synthetic Biology for Engineering Applications (R01 Clinical Trial Optional)"
  (NOT-EB-20-010)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  

• Notice to Extend the Application Due Date and Expiration Date for RFA-HD-21-016 "Collaborative Pediatric Critical Care Research Network (PL1) (Clinical Trial Required)"
  (NOT-HD-20-023)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice to Extend, "PAR-17-264 " Innovative Mental Health Services Research Not Involving Clinical Trials (R01)
  (NOT-MH-20-063)
  National Institute of Mental Health
  

• Notice to Extend Eligibility for Submission of Diversity K22 Applications due to COVIDrelated Disruptions
  (NOT-NS-20-076)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change to Key Dates for PAR-18-665 "NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)"
  (NOT-NS-20-077)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Corrections to RFA-OD-20-013 "Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)" Budget and Review
  (NOT-OD-20-140)
  National Institutes of Health
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Glioblastoma Therapeutics Network (U19 Clinical Trial Required)
  (NOT-CA-20-073)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional)
  (NOT-MH-20-065)
  National Institute of Mental Health
  

Requests for Proposal

• Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers
  (NOT-CA-20-077)
  National Cancer Institute
  

Notices of Special Interest

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
  (NOT-OD-20-129)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
  (PA-20-242)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 Clinical Trial Not Allowed)
  (PAR-20-239)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 4, 2020; September 3, 2021; September 2, 2022
  
  

• NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)
  (PAR-20-240)
  National Institute of Neurological Disorders and Stroke
  National Institute of Mental Health
  Application Receipt Date(s): January 25, 2021, September 27, 2021, and September 26, 2022 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)
  (PAR-20-241)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 30, 2020
  
  

• Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
  (PAR-20-243)
  National Institute of Mental Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): August 20, 2020, December 2 , 2020, March 2, 2021
  
  

• Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 Clinical Trial Not Allowed)
  (PAR-20-244)
  National Institute of General Medical Sciences
  Application Receipt Date(s): September 4, 2020; September 3, 2021; September 2 , 2022
  
  

• Collaborative Partnership between Research Centers in Minority Institutions (RCMI) and Alcohol Research Centers (U54 Clinical Trial Optional)
  (RFA-AA-20-010)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): October 7, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement..
  
  

• Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed)
  (RFA-AG-21-026)
  National Institute on Aging
  Application Receipt Date(s): November 10, 2020
  
  

• 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
  (RFA-CA-20-042)
  National Cancer Institute
  Application Receipt Date(s): November 9, 2020
  
  

• Characterizing causal mechanisms to prevent dental fear and anxiety (R01 Basic Experimental Studies with Humans Required)
  (RFA-DE-21-001)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 10, 2020
  
  

• Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed)
  (RFA-HD-21-008)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): December 3, 2020